However, this efficacy was not accompanied by the severe toxicities reported in patients treated with cetuximab. The results further conclude that this trial challenges the adopted tenet that
Innovative Spinal is engaged in the development of spinal products. The company develops fixation systems and motion preservation products used in the treatment of spinal disorders. It is
An initial order of $90 million of vaccine has been placed, with the potential for additional orders. This project has been funded in whole or in part with
The proposals include: The Advanced Medical Technology Association said it would take initiatives to reduce medical errors, for example by improving the design of medical devices. America’s Health
Under this agreement, AstraZeneca and Merck will work together to evaluate co-administration of the compounds in a Phase I clinical trial for the treatment of solid cancer tumors.
NxStage said its Medisystems in-center business has completed development of the new Streamline blood tubing sets for use on the B. Braun Dialog and Dialog Plus hemodialysis systems
Frank Baldino, Chairman and CEO, Cephalon, said:” We are proud to be able to bring Nuvigil to physicians and patients and to increase access to the medication through
Dimitris Voliotis, Vice President, Nexavar Clinical Development, Bayer HealthCare Pharmaceuticals, said: Nexavar has proven efficacy in liver cancer and kidney cancer and we are committed to researching Nexavar
GE Healthcare plans to set up a new breast cancer team at QSTP in Doha, Qatar. Based at GE’s Advanced Technology & Research Centre in QSTP in Doha,
EZN-2968 is the first clinical product candidate to target the HIF-1 transcription factor. HIF-1 regulates expression of many key genes important in cancer biology. Jeffrey Buchalter, Enzon’s Chairman
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.